These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 13794908)

  • 1. The effects of sodium citrate and an excess of plasminogen on fibrinolytic agents.
    ASTRUP T; STERNDORFF I
    Thromb Diath Haemorrh; 1960 Jun; 4():462-72. PubMed ID: 13794908
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of clotting as the result of plasminogen activation by streptokinase. 2. Analytical studies of the clotting mechanism.
    BELLER FK; GLAS P
    Thromb Diath Haemorrh; 1960 Jun; 4():520-33. PubMed ID: 13798543
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of plasmin (fibrinolysin) on blood coagulation factors].
    JUNG EG; DUCKERT F
    Schweiz Med Wochenschr; 1960 Oct; 90():1239-41. PubMed ID: 13791043
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous administration of fibrinolysin: its systemic toxicity and effect upon components of the coagulation mechanism.
    MOSER KM
    Angiology; 1959 Aug; 10():253-8. PubMed ID: 14424539
    [No Abstract]   [Full Text] [Related]  

  • 5. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sodium citrate on the fibrinolytic activity of plasmin and trypsin.
    MULLERTZ S
    Arch Biochem Biophys; 1952 Nov; 41(1):235-6. PubMed ID: 12997268
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the effect of polycarbonic acid on the blood coagulation system].
    WILLE P
    Z Gesamte Inn Med; 1960 Sep; 15():817-20. PubMed ID: 13785352
    [No Abstract]   [Full Text] [Related]  

  • 8. Assay procedure for the quantitative determination of clot lysis activity.
    BAUMGARTEN W; CIMINERA JL; COLE RB
    Vox Sang; 1960 Sep; 5():416-24. PubMed ID: 13688014
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of clotting as the result of plasminogen activation by streptokinase. 1. Studies of the inactivation of fibrinogen.
    GLAS P; BELLER FK
    Thromb Diath Haemorrh; 1960 Jun; 4():507-19. PubMed ID: 13828336
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of fibrinolysin on the coagulation mechanism.
    GOLLUB S
    SD J Med Pharm; 1961 Sep; 14():347-51. PubMed ID: 13706720
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on fibrinolytic agent-platelet interaction (author's transl)].
    Mishina Y; Watada M
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):154-60. PubMed ID: 4277931
    [No Abstract]   [Full Text] [Related]  

  • 12. A new fibrinolytic and anticoagulant enzyme.
    ADAMIS DM
    Lancet; 1961 Nov; 2(7211):1070. PubMed ID: 13859264
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of citrate on euglobulin methods of estimating fibrinolytic activity.
    BUCKELL M
    J Clin Pathol; 1958 Sep; 11(5):403-5. PubMed ID: 13575554
    [No Abstract]   [Full Text] [Related]  

  • 14. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS.
    LEWIS JH; SHIRAKAWA M
    Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448
    [No Abstract]   [Full Text] [Related]  

  • 15. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS.
    LEWIS JH; KERBER CW; WILSON JH
    Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of various plasma components on the lysis of dilute human blood clots.
    Gallimore MJ; Shaw JT
    Thromb Diath Haemorrh; 1969 Nov; 22(2):223-33. PubMed ID: 5380946
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental study of biosoluble drugs. Thrombus lysis with biosoluble immobilized fibrinolysin in experiment.
    Chazov EI; Mazaev AV; Torchilin VP; Lebedev BS; Il'ina EV; Smirnov VN
    Thromb Res; 1978 May; 12(5):809-16. PubMed ID: 150065
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood clotting activities of thrombolytic agents with special reference to a Hageman-like effect.
    IATRIDIS SG; WILSON EG; FERGUSON JH; RIERSON HA
    Thromb Diath Haemorrh; 1960 Oct; 5():50-60. PubMed ID: 13717314
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of plasmin in vitro on clotting factors in plasma.
    DONALDSON VH
    J Lab Clin Med; 1960 Oct; 56():644-51. PubMed ID: 13723695
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrinolytic and thrombolytic properties of plasmin (a preparation of streptolyase-activated plasminogen)].
    Andreenko GV; Murav'eva NF; Kanygina ED; Liutova LV; Karabasova MA
    Gematol Transfuziol; 1986 Mar; 31(3):27-32. PubMed ID: 2941333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.